FMR LLC 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 4,292,881 14.942% | 943,407![]() (+28.17%) | Filing |
2024-02-12 12:03 pm Purchase | 2024-02-09 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 3,349,474 11.874% | 963,576![]() (+40.39%) | Filing |
2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 2,385,898 8.458% | -227,374![]() (-8.70%) | Filing |
2023-05-10 09:45 am Purchase | 2023-05-09 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 2,613,272 10.133% | 504,419![]() (+23.92%) | Filing |
2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 2,108,853 8.190% | 130,564![]() (+6.60%) | Filing |
2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,978,289 7.879% | 725,903![]() (+57.96%) | Filing |
2021-02-08 10:27 am Purchase | 2021-02-05 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,252,386 6.354% | 104,100![]() (+9.07%) | Filing |